Tests to be Conducted. In conducing the testing authorized by this Agreement, the Employer shall:
(a) use only a clinical laboratory or hospital facility that is licensed pursuant to the Illinois Clinical Laboratory Act that has or is capable of being accredited by the National Institute of Drug Abuse (NIDA) and Department of Transportation (DOT)
(b) select a laboratory or facility that conforms to all NIDA standards and DOT;
(c) establish a chain of custody procedure for both the sample collection and testing that will ensure the integrity of the identity of each sample and test result;
(d) collect a sufficient sample of the bodily fluid or material from an employee to allow for initial screening, a confirmatory test and a sufficient amount to be set aside reserved for later testing, if requested by the employee;
(e) collect samples in such a manner as to preserve the individual employee’s right to privacy, ensure a high degree of security for the sample and its freedom from adulteration;
(f) confirm any sample that tests positive in the initial screening for drugs by re-testing the second portion of the same sample by gas chromatography mass spectrometry (GCMS) or an equivalent or better scientifically accurate and accepted method that provides quantitative data about the detected rug or drug metabolites;
(g) provide the tested employee with the opportunity to have an additional sample tested by a clinical laboratory or hospital facility of the employee’s own choosing, at the employee’s own expense; provided the employee notifies the Employer within seventy-two (72) hours of receiving the results of the tests;
(h) require that a laboratory or hospital facility report to the Employer that a blood or urine sample is positive only if both the initial screening and the confirmation tests are positive for a particular drug. The parties agree that should any information concerning such testing or the results thereof be obtained by the Employer inconsistent with the understandings expressed herein (e.g., xxxxxxxx for testing that reveal the nature or number of the tests administered), the Employer will not use such information in any manner or forum adverse to the employee’s interest;
(i) require that with regard to drug testing, for the purpose of determining whether the employee is under the influence of drugs on a 5 panel drug test with test results higher than the following: Amphetamines 1000ng/ml Cocaine Metabolites 300ng/ml Marijuana Metabolites 50ng/ml Opiates 2000ng/ml Phency...
Tests to be Conducted. In conducting the testing authorized by this Agreement, the Employer shall:
A. Use only a clinical laboratory or hospital facility that is licensed pursuant to the Illinois Clinical Laboratory Act that has or is capable of being accredited by the Substance Abuse and Mental Health Services Administration (SAMHSA); and which has a medical review officer on staff to review the records.
B. Ensure that the laboratory or facility selected conforms to all SAMHSA standards.
C. Establish a chain of custody procedure for both the sample collection and testing that will ensure that integrity of the identity of each sample and test result. No Employee covered by this Agreement shall be permitted at any time to become a part of such chain of custody.
D. Collect a sufficient sample of the same bodily fluid or material from an Employee to allow for initial screening, a confirmatory test resolved for later testing if requested by the Employee.
E. Collect samples in such a manner as to preserve the individual Employee’s right to privacy, but also to insure a high degree of security for the sample and its freedom from adulteration.
F. Confirm any sample that tests positive in the initial screening for drugs by testing the second portion of the same sample by gas chromatography mass spectrometry (GCMS) or an equivalent, or better scientifically accurate and accepted method that provides quantitative data about the detected drug or drug metabolites.
G. Provide the employee tested with an opportunity to have the additional reserved sample tested by a clinical laboratory or hospital facility of the employee’s own choosing, at the employee’s expense; provided the employee notifies the Employer within seventy-two hours of receiving the results of the test, and provided that the clinical laboratory or hospital facility conforms the same criteria as set forth above.
H. Require that the laboratory or hospital facility report to the Employer that a blood or urine sample is positive only if both the initial screening and confirmation test is positive for a particular drug. The parties agree that should any information concerning such testing or results thereof be obtained by the Employer inconsistent with the understanding expressed herein (e.
Tests to be Conducted. In conducting the testing authorized by this Agreement, the Village of Chatham shall follow the guidelines of the 3rd party vendor, Midwest Trucker’s Association. Said guidelines are attached as Appendix A.
a) Use only a clinical laboratory or hospital facility that is licensed pursuant to the Illinois Clinical Laboratory Act that has or is capable of being accredited by the National Institute of Drug Abuse (NIDA);
b) Insure that the laboratory or facility selected conforms to all NIDA standards;
c) Establish a chain of custody procedure for both collection and testing that will insure the integrity of the identity of each sample and test result. No employee covered by this Agreement shall be permitted at any time to become a part of such chain of custody;
d) Collect a sufficient sample of the same bodily fluid or material from an officer to allow for initial screening, a confirmatory test and a sufficient amount to be set aside reserved for later testing if requested by the employee;
e) Collect samples in such a manner as to insure a high degree of security for the sample and its freedom from adulteration;
f) Confirm any sample that tests positive in the initial screening for drugs by testing the second portion of the same sample by gas chromatography mass spectrometry (gcms) or an equivalent or better scientifically accurate and accepted method that provides quantitative data about the detected drug or drug metabolites;
g) Provide the employee tested with an opportunity to have the additional sample tested by a clinical laboratory or hospital facility of the employee’s own choosing, at the employee’s own expense; provided the employee notifies the Village of Chatham within seventy-two (72) hours of receiving the results of the tests;
h) Require that the laboratory or hospital facility report to the Village of Chatham that a blood or urine sample is positive only if both the initial screening and confirmation test are positive for a particular drug. The parties agree that should any information concerning such testing or the results thereof be obtained by the Village of Chatham inconsistent with the understandings expressed herein (e.g., xxxxxxxx for testing that reveal the nature or number of tests administered), the City will not use such information in any manner or forum adverse to the employee’s interests;
i) Require that with regard to alcohol testing, for the purpose of determining whether the employee is under the influence of alcohol, test result...
Tests to be Conducted. For drug testing, the Employer shall use only a clinical laboratory or hospital facility that is licensed per the Illinois Clinical Laboratory Act, which shall comply with N.I.D.A. and D.O.T. standards.
Tests to be Conducted. In conducting the testing authorized by this Agreement the University shall:
a) Use only a clinical laboratory or hospital facility that is licensed pursuant to the Illinois Clinical Laboratory Act that has been accredited by the Substance Abuse and Mental Health Services Administration (SAMSHA);
b) Use as the initial screening immunoassay (IA) step a rapid semi-quantitative chemical test which uses a specific antibody to react with the drug or metabolite of interest. The confirmation assay used in the drug or metabolite of interest. The confirmation assay used in the drug analysis procedure shall be Gas Chromatography/Mass Spectrometry (GC/MS), or an equivalent or better scientifically accurate and accepted method that provides quantitative data about the detected drug or drug metabolites;
c) Establish a chain of custody procedure for both sample collection and testing that will ensure the integrity of each sample and test result. No employee covered by the Agreement shall be permitted at any time to become a part of such chain of custody;
d) Collect a sufficient sample of the same bodily fluid or material for the purpose of drug testing of an employee to allow for initial screening, a confirming test and a sufficient amount to be set aside reserved for later testing if requested by the employee. This will not apply to alcohol testing as this will be done on a breathalyzer as specified by Section 14.5,
Tests to be Conducted. The Employer shall use a clinical laboratory or hospital facility that is licensed per the Illinois Clinical Laboratory Act, which laboratory shall comply with all NIDA standards. The Employer shall establish a chain of custody procedure to insure the integrity of samples and test results, and shall not permit the employee or any other bargaining unit member to be part of such chain. Sufficient samples shall be collected so as to permit an initial, a confirmatory test, and a subsequent test to be arranged at a facility of the employee's choosing. Confirmatory testing shall be by gas chromatography/mass spectrometry (GCMS) or an equivalent scientifically accurate test. In cases where the Employer has probable cause to suspect alcohol consumption, the Employer may require the employee to submit to a breathalyzer test or intoximeter.
Tests to be Conducted. In conducting the testing authorized by this Agreement, the City shall:
a. Use only a clinical laboratory or hospital facility that is licensed pursuant to the Illinois Clinical Laboratory Act.
b. Insure that the laboratory or facility selected conforms to all State of Illinois testing standards;
c. Establish a chain of custody procedure for both sample collection and testing will insure the integrity of the identity of each sample and test result. No employee below the rank of Lieutenant covered by this Agreement shall be permitted at any time to become a part of such chain of custody.
d. Collect a sufficient sample of the same bodily fluid or material from an employee to allow for initial screening, a confirmatory test and a sufficient amount to be set aside reserved for later testing if requested by the employee;
e. Collect samples in such a manner as to preserve the individual employee’s right to privacy, insure a high degree of security of the sample and its freedom from adulteration. Employees shall not be witnessed by anyone while submitting a sample, except in circumstances where the laboratory or facility does not have a “clean room” for submitting samples or where there is reasonable belief that the employee has attempted to compromise the accuracy of the testing procedure;
f. Confirm any sample that test positive in the initial screening for drugs by testing the second portion of the same sample by gas chromatography, plus mass spectrometry or an equivalent or better scientifically accurate and accepted method that provides quantitative data about the detected drug metabolites;
g. Provide the employee tested with an opportunity to have the additional sample tested by a clinical laboratory or hospital facility of the employee’s own choosing, at the employee’s own expense; provided the employee notifies the Chief within seventy-two (72) hours of receiving the results of the tests;
h. Require that the laboratory or hospital facility report to the City that a blood or urine sample is positive only if both the initial screening and confirmation test are positive only if both the initial screening and confirmation test are positive for a particular drug. The parties agree that should any information concerning such testing or the results thereof be obtained by the City inconsistent with the understandings expressed herein (e.
Tests to be Conducted. For drug testing, the Employer shall use only a clinical laboratory or hospital facility that is licensed per the Illinois Clinical Laboratory Act, which shall comply with N.I.D.A. and D.O.T. standards. 1879 1880 1881 1882 1883 1884 1885 1886 1887 1888 1889 1890 1891 1892 1893 1894 1895 1896 1897 1898 1899 1900 1901 1902 1903 1904 1905 1906 1907 1908 1909
Tests to be Conducted. In conducting the testing authorized by this Agreement, the City shall:
(A) Utilize only those breathalyzer, urine or other tests or testing methods and devices which are recognized as reliable by the Illinois Department of Public health or other public agencies who monitor and regulate drug and alcohol testing within the State of Illinois.
(B) Collect samples in such a manner as to preserve the individual employee’s right to privacy, insure a high degree of security for the sample and its freedom from adulteration.
(C) In the case of alcohol testing, any positive Breathalyzer test shall immediately be followed by a second, confirmatory test. Upon a second positive test, the employee tested shall have the opportunity to immediately submit to a blood or urine test by a clinical laboratory or hospital facility of the employee’s own choosing, at the employee’s own expense, provided that said laboratory is licensed pursuant to the Illinois Clinical Laboratory Act. Employees who submit to clinical testing shall provide copies of laboratory results to the City within seventy-two (72) hours of their receipt.
Tests to be Conducted. In conducting the testing authorized by this Agreement, the City shall:
a. Use only a clinical laboratory or hospital facility that is licensed pursuant to the Illinois Clinical Laboratory Act that has or is capable of being accredited by the Substance Abuse and Mental Health Services Administration (SAMHSA) b. insure that the laboratory or facility selected conforms to all SAMHSA standards;
